MSCI (MSCI) Competitors $546.73 +4.17 (+0.77%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$555.25 +8.52 (+1.56%) As of 04/17/2025 06:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock MSCI vs. CME, ICE, MCO, IBKR, NDAQ, MKTX, AROW, PHH, UBER, and PDDShould you be buying MSCI stock or one of its competitors? The main competitors of MSCI include CME Group (CME), Intercontinental Exchange (ICE), Moody's (MCO), Interactive Brokers Group (IBKR), Nasdaq (NDAQ), MarketAxess (MKTX), Arrow Financial (AROW), PHH (PHH), Uber Technologies (UBER), and PDD (PDD). MSCI vs. CME Group Intercontinental Exchange Moody's Interactive Brokers Group Nasdaq MarketAxess Arrow Financial PHH Uber Technologies PDD CME Group (NASDAQ:CME) and MSCI (NYSE:MSCI) are both large-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership, valuation and community ranking. Do analysts rate CME or MSCI? CME Group presently has a consensus price target of $247.47, suggesting a potential downside of 5.74%. MSCI has a consensus price target of $643.92, suggesting a potential upside of 17.78%. Given MSCI's stronger consensus rating and higher probable upside, analysts plainly believe MSCI is more favorable than CME Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CME Group 4 Sell rating(s) 7 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.13MSCI 0 Sell rating(s) 3 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.79 Is CME or MSCI a better dividend stock? CME Group pays an annual dividend of $5.00 per share and has a dividend yield of 1.9%. MSCI pays an annual dividend of $7.20 per share and has a dividend yield of 1.3%. CME Group pays out 51.7% of its earnings in the form of a dividend. MSCI pays out 51.2% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. MSCI has increased its dividend for 11 consecutive years. Does the media favor CME or MSCI? In the previous week, CME Group had 8 more articles in the media than MSCI. MarketBeat recorded 56 mentions for CME Group and 48 mentions for MSCI. CME Group's average media sentiment score of 0.98 beat MSCI's score of 0.76 indicating that CME Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CME Group 31 Very Positive mention(s) 5 Positive mention(s) 14 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive MSCI 19 Very Positive mention(s) 11 Positive mention(s) 13 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is CME or MSCI more profitable? CME Group has a net margin of 57.52% compared to MSCI's net margin of 38.83%. CME Group's return on equity of 13.62% beat MSCI's return on equity.Company Net Margins Return on Equity Return on Assets CME Group57.52% 13.62% 2.81% MSCI 38.83%-156.08%22.03% Do institutionals and insiders hold more shares of CME or MSCI? 87.8% of CME Group shares are owned by institutional investors. Comparatively, 90.0% of MSCI shares are owned by institutional investors. 0.3% of CME Group shares are owned by company insiders. Comparatively, 3.3% of MSCI shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in CME or MSCI? CME Group received 120 more outperform votes than MSCI when rated by MarketBeat users. However, 66.03% of users gave MSCI an outperform vote while only 58.67% of users gave CME Group an outperform vote. CompanyUnderperformOutperformCME GroupOutperform Votes67058.67% Underperform Votes47241.33% MSCIOutperform Votes55066.03% Underperform Votes28333.97% Which has more risk and volatility, CME or MSCI? CME Group has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, MSCI has a beta of 1.3, meaning that its stock price is 30% more volatile than the S&P 500. Which has stronger valuation & earnings, CME or MSCI? CME Group has higher revenue and earnings than MSCI. CME Group is trading at a lower price-to-earnings ratio than MSCI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCME Group$6.13B15.43$3.53B$9.6727.15MSCI$2.86B14.86$1.11B$14.0638.89 SummaryMSCI beats CME Group on 12 of the 22 factors compared between the two stocks. Get MSCI News Delivered to You Automatically Sign up to receive the latest news and ratings for MSCI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MSCI vs. The Competition Export to ExcelMetricMSCIBusiness services IndustryFinance SectorNYSE ExchangeMarket Cap$42.45B$19.39B$10.83B$18.41BDividend Yield1.36%2.92%5.97%4.20%P/E Ratio38.8932.0621.6731.07Price / Sales14.866.9425.4326.55Price / Cash31.8932.3017.6117.53Price / Book-45.184.932.564.30Net Income$1.11B$681.55M$1.03B$1.02B7 Day Performance0.82%1.00%1.88%1.42%1 Month Performance-3.83%-8.95%-3.66%-7.32%1 Year Performance8.17%13.84%535.25%2.27% MSCI Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MSCIMSCI4.7107 of 5 stars$546.73+0.8%$643.92+17.8%+6.8%$42.45B$2.86B38.894,760Upcoming EarningsAnalyst ForecastCMECME Group3.9845 of 5 stars$264.13+1.0%$247.47-6.3%+26.0%$95.18B$6.13B27.313,460Upcoming EarningsICEIntercontinental Exchange4.1635 of 5 stars$159.94+2.6%$182.47+14.1%+21.1%$91.89B$11.76B33.4612,920Insider TradePositive NewsMCOMoody's4.6812 of 5 stars$437.83+2.2%$524.86+19.9%+13.0%$78.76B$7.09B38.8514,400Upcoming EarningsAnalyst ForecastInsider TradePositive NewsIBKRInteractive Brokers Group4.6898 of 5 stars$174.69+1.9%$195.88+12.1%+46.0%$73.82B$9.32B24.742,820Earnings ReportAnalyst ForecastStock SplitShort Interest ↓NDAQNasdaq4.6426 of 5 stars$72.88+1.9%$85.63+17.5%+20.3%$41.92B$7.40B37.966,380Upcoming EarningsAnalyst UpgradeAnalyst RevisionNews CoverageMKTXMarketAxess4.6358 of 5 stars$222.00+0.1%$252.11+13.6%+11.5%$8.37B$817.10M30.54740Analyst RevisionPositive NewsAROWArrow Financial4.6701 of 5 stars$23.90-1.0%$31.00+29.7%+9.4%$399.56M$139.81M13.50510Analyst DowngradeGap UpPHHPHHN/A$12.81-1.3%N/AN/A$335.62M$2.38M0.0033Gap UpUBERUber Technologies4.7999 of 5 stars$73.36+1.5%$89.97+22.6%+4.7%$153.45B$43.98B16.0932,800Analyst ForecastAnalyst RevisionPDDPDD4.652 of 5 stars$95.60+5.6%$169.91+77.7%-17.4%$131.53B$393.84B9.3412,992 Related Companies and Tools Related Companies CME Alternatives ICE Alternatives MCO Alternatives IBKR Alternatives NDAQ Alternatives MKTX Alternatives AROW Alternatives PHH Alternatives UBER Alternatives PDD Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MSCI) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MSCI Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MSCI With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.